Gold-based metallodrugs have been used for a wide variety of medical–related applications. Although none of them have reached clinical trials, many compounds show potential for a plethora of possible applications. Platinum compounds, on the other hand, are the leading class of metallodrugs used for the treatment of cancer, with successful representatives worldwide, such as cisplatin, carboplatin and oxaliplatin. In this minireview, we will briefly present the development of metallodrugs based on such metals throughout the year of 2017.